Skip to main content
Vivian Wu, MD, Otolaryngology (ENT), Santa Monica, CA

VivianWuMD

Otolaryngology (ENT) Santa Monica, CA

Head & Neck Microvascular Surgery, Head & Neck Oncologic Surgery

Surgeon, Otolaryngology/Head & Neck Surgical Oncology

Dr. Wu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wu's full profile

Already have an account?

  • Office

    Arizona ave
    Santa Monica, CA 90404

Summary

  • Dr. Vivian Wu is an Otolaryngologist in Los Angeles. She specializes in Head & Neck Oncologic Surgery. Her training includes a fellowship in Head & Neck Surgical Oncology at the University of Michigan Health System and a residency in Otolaryngology - Head and Neck Surgery at Oregon Health & Science University. She has also authored several well-cited publications in the fields of surgical pathology and oncology.

Education & Training

  • University of Michigan Health System
    University of Michigan Health SystemFellowship, Head & Neck Surgical Oncology/Microvascular Reconstruction, 2011 - 2013
  • Oregon Health & Science University (OHSU Health)
    Oregon Health & Science University (OHSU Health)Residency, Otolaryngology - Head and Neck Surgery, 2004 - 2011
  • Howard University College of Medicine
    Howard University College of MedicineClass of 2004

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2010 - Present
  • MI State Medical License
    MI State Medical License 2011 - 2027
  • CA State Medical License
    CA State Medical License 2024 - 2026
  • VA State Medical License
    VA State Medical License 2013 - 2018
  • American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Publications & Presentations

PubMed

Press Mentions

  • Nektar Therapeutics Presents New Data from Its Immuno-Oncology Pipeline at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
    Nektar Therapeutics Presents New Data from Its Immuno-Oncology Pipeline at the 2020 Society for Immunotherapy of Cancer (SITC) Annual MeetingNovember 11th, 2020
  • Nektar Therapeutics Announces Publication of Results from Phase 1 Dose-Escalation Study for Bempegaldesleukin plus Nivolumab in 'Cancer Discovery' Journal
    Nektar Therapeutics Announces Publication of Results from Phase 1 Dose-Escalation Study for Bempegaldesleukin plus Nivolumab in 'Cancer Discovery' JournalMay 22nd, 2020
  • Hospitals Don’t Shift Costs from Medicare or Medicaid to Private Insurers
    Hospitals Don’t Shift Costs from Medicare or Medicaid to Private InsurersJune 8th, 2017